GENE | HGNC_ID | MARKER_TYPE | CANCER_TYPE | HISTOLOGICAL_TYPE | CELL_LINE | CSC_ENRICHMENT | METHOD | EXPRESSION_LEVEL | CONFIDENCE_SCORING | GLOBAL_SCORING | PUBMED_ID |
---|
ABCB1 | 40 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | NA | RT-PCR | NA | 0.2 | 0.0604 | 29902974
|
ALDH1A1 | 402 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | NA | RT-PCR | NA | 0.2 | 0.684 | 29902974
|
LGR5 | 4504 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | NA | RT-PCR | NA | 0.2 | 0.0753 | 29902974
|
NAMPT | 30092 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | NA | qRT-PCR followed by SFA and CFA | NA | 0.2 | 0.0032 | 29203587
|
NANOG | 20857 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | NA | RT-PCR | NA | 0.2 | 0.5461 | 29902974
|
PROM1 | 9454 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | NA | RT-PCR | NA | 0.2 | 0.7582 | 29902974
|
CD24 | 1645 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | Doxorubicin | FACs followed by SFA | NA | 0.12 | 0.456 | 30344742
|
CD44 | 1681 | LTM | Dukes Type B Colon Cancer | Adenocarcinoma | LS180 | Doxorubicin | FACs followed by SFA | NA | 0.12 | 1 | 30344742
|